Ozempic And Wegovy
- All
- News
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
